KACTUS, a leading recombinant protein manufacturer, has published a technical framework for engineering 2+1 and trispecific T-cell engager (TCE) therapeutics.
KACTUS, a biotechnology research reagent provider based in Waltham, Massachusetts, announced the commercial availability of ultra-low endotoxin recombinant human kallikrein-1 proteins designed to ...
Breeders' Cup Mile (G1T) winner Tourist was represented by his first winner July 1 at Emerald Downs as his juvenile daughter Kactus Kate scored by two lengths on debut in a maiden special weight over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results